Stem Cell Therapy Market is expected to increase at a compound annual growth rate (CAGR) of 18.5% from 2025 to 2035
The stem cell
therapy market is estimated to be worth USD 296 million in 2024 and is
expected to grow at a compound annual growth rate (CAGR) of 18.5% to reach USD
1.8 billion by 2035. They are important in the treatment of blood diseases and
malignancies. Immunological modulation, tissue regeneration, drug discovery,
and personalized medicine are just a few of the many uses for stem cell
therapy.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/stem-cell-therapy-market
GROWTH
DRIVERS
Increased
funding for stem cell research is largely responsible for the growth of the
stem cell therapy business. In order to foster an atmosphere that is conducive
to stem cell treatment research and development, financial support and
government actions are essential. The investment speeds up clinical trials,
facilitates the conversion of research discoveries into practical therapeutic
applications, increases industrial capacity and infrastructure, and helps the
stem cell treatment market grow and mature overall.
MARKET
SEGMENTATION:
By Type -
· Adult
Stem Cells (ASCs)
o Hematopoietic
o Mesenchymal
o Neural
o Epithelial/Skin
o Others
· Induced
Pluripotent Stem Cells (iPSCs)
· Embryonic
Stem Cells (ESCs)
· Human
Embryonic Stem Cells (HESCs)
· Other
Stem Cells
By
Therapy Type -
· Autologous
Stem Cell Therapy
· Allogenic
Stem Cell Therapy
By Cell
Source -
· Bone
Marrow
· Adipose
Tissue
· Placental/Umbilical
Cord Blood
· Dental
Pulp
· Others
By
Application -
· Neurological
Disorders
· Cardiovascular
Diseases
· Orthopedic
Treatments
· Oncology
· Diabetes
· Surgeries
· Inflammatory
& Autoimmune Diseases
· Wound
Healing and Tissue Regeneration
· Others
By
End-User -
· Hospitals
& Clinics
· Research
Institutes
· Biotechnology
Companies
· Contract
Research Organizations (CROs)
By Region -
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East and Africa
Global
Key Players:
· Athersys
Inc.
· Mesoblast
Ltd
· Biorestorative
Therapies Inc.
· Pluristem
Inc.
· Brainstorm
Cell Limited
· ViaCyte
Inc.
· Gamida
Cell
· HOPE
BIOSCIENCES
· Cellular
Biomedicine Group
· Smith
& Nephew
· MEDIPOST
· ANTEROGEN.
C.O., LTD.
· NuVasive
Inc.
· RTI
Surgical
· AlloSource
· JCR
Pharmaceuticals Co. Ltd.
· Takeda
Pharmaceutical Company Limited
For More Information about this Report @
https://www.xresearch.biz/shop/stem-cell-therapy-market
About Us: -
xResearch
is a market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment